Literature DB >> 9322270

Effects of diagnosis on treatment recommendations in chronic insomnia--a report from the APA/NIMH DSM-IV field trial.

D J Buysse1, C F Reynolds, D J Kupfer, M J Thorpy, E Bixler, A Kales, R Manfredi, A Vgontzas, E Stepanski, T Roth, P Hauri, D Stapf.   

Abstract

The objective of this study was to determine whether sleep specialists and nonspecialists recommend different treatments for different insomnia diagnoses according to two different diagnostic classifications. Two hundred sixteen patients with chronic insomnia at five sites were each interviewed by two clinicians: one sleep specialist and one nonsleep specialist. All interviewers indicated diagnoses using the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV); sleep specialists also indicated diagnoses according to the International Classification for Sleep Disorders (ICSD). Interviewers then indicated how strongly they would recommend each item in a standard list of treatment and diagnostic interventions for each patient. We examined differences in treatment recommendations among the six most common DSM-IV diagnoses assigned by sleep specialists at different sites (n = 192), among the six most common ICSD diagnoses assigned by sleep specialists at different sites (n = 153), and among the six most common DSM-IV diagnoses assigned by nonspecialists at different sites (n = 186). In each analysis, specific treatment and polysomnography recommendations differed significantly for different diagnoses, using either DSM-IV or ICSD criteria. Conversely, different diagnoses were associated with different rank orderings of specific treatment and diagnostic recommendations. Sleep specialist and nonspecialist interviewers each distinguished treatment recommendations among different diagnoses, but in general, nonspecialists more strongly recommended medications and relaxation treatments. Significant site-related differences in treatment recommendations also emerged. Differences in treatment recommendations support the distinction between different DSM-IV and ICSD diagnoses, although they do not provide formal validation. Site-related differences suggest a lack of consensus in how these disorders are conceptualized and treated.

Entities:  

Mesh:

Year:  1997        PMID: 9322270     DOI: 10.1093/sleep/20.7.542

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  11 in total

1.  Insomnia in untreated sleep apnea patients compared to controls.

Authors:  Erla Björnsdóttir; Christer Janson; Thorarinn Gíslason; Jón F Sigurdsson; Allan I Pack; Philip Gehrman; Bryndís Benediktsdóttir
Journal:  J Sleep Res       Date:  2011-10-12       Impact factor: 3.981

2.  Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial.

Authors:  Philip Cheng; David A Kalmbach; Gabriel Tallent; Christine Lm Joseph; Colin A Espie; Christopher L Drake
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

3.  Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Authors:  Andrew D Krystal; Alan Lankford; H Heith Durrence; Elizabeth Ludington; Philip Jochelson; Roberta Rogowski; Thomas Roth
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

4.  Effects of a Multi-Component Behavioral Intervention (MCI) for Insomnia on Depressive and Insomnia Symptoms in Individuals with High and Low Depression.

Authors:  Kirsten Johnson; Souraya Sidani; Dana R Epstein
Journal:  J Evid Inf Soc Work       Date:  2015-03-20

5.  Sleep hygiene behaviors among midlife women with insomnia or sleep-disordered breathing: the SWAN sleep study.

Authors:  Christopher E Kline; Leah A Irish; Daniel J Buysse; Howard M Kravitz; Michele L Okun; Jane F Owens; Martica H Hall
Journal:  J Womens Health (Larchmt)       Date:  2014-10-29       Impact factor: 2.681

6.  Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.

Authors:  Graham J Emslie; Betsy D Kennard; Taryn L Mayes; Paul A Nakonezny; Lian Zhu; Rongrong Tao; Carroll Hughes; Paul Croarkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-01-18       Impact factor: 2.576

7.  Improved resilience following digital cognitive behavioral therapy for insomnia protects against insomnia and depression one year later.

Authors:  Philip Cheng; David A Kalmbach; Hsing-Fang Hsieh; Andrea Cuamatzi Castelan; Chaewon Sagong; Christopher L Drake
Journal:  Psychol Med       Date:  2022-03-08       Impact factor: 10.592

Review 8.  Cognitive-behavioral therapy for the management of insomnia comorbid with mental disorders.

Authors:  María Montserrat Sánchez-Ortuño; Jack D Edinger
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

9.  Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Authors:  Thomas Roth; Roberta Rogowski; Steven Hull; Howard Schwartz; Gail Koshorek; Bruce Corser; David Seiden; Alan Lankford
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

10.  Neurophysiological Processing of an Emotional Task is Sensitive to Time-of-Day.

Authors:  Isaac Chayo; Mercedes Fernandez; Samantha Sandor; Jaime L Tartar
Journal:  J Circadian Rhythms       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.